 | A. D. Seidman - Antineoplastic agents - 2001 - 108 pages
...cancer: A phase II siudy. J Clin Oncol 1 999; Apr; 1 714): 1118. [40] Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody...breast cancer that overexpresses HER2. N Engl J Med 200 1 ; Mar 1 5:3441 1 1 ):783-792. [41] Perez EA, Hortobagyi GN, Ongoing and planned adjuvant trials... | |
 | Yao-Shan Fan - Medical - 2008 - 409 pages
...therapy. Breast Cancer Res. Treat. 51, 65-77. 68. Slamon, DJ, Leyland- Jones, B., Shak, S., et al. (2001) Use of chemotherapy plus a monoclonal antibody against...breast cancer that overexpresses HER2. N. Engl. J. Med. 344, 783-792. 69. Genentech Inc. (1998) Herceptin (Trastuzumab) Package Inserte (unpublished) 70. Slamon,... | |
 | John A. Wagner - Medical - 2002 - 76 pages
...Fuchs, V. Paton, A. Bajamonde, T. Fleming, W. Eiermann, J. Wolter, M. Pegram. J. Baselga and L. Norton, Use of chemotherapy plus a monoclonal antibody against...metastatic breast cancer that overexpresses HER2, N. Eng. J Med. 1344 (2001 ), 783-792. [6] ID Walton, LJ Dietz, G. Frenzel, J. Chen, J. Winkler, SM Norton... | |
 | Susanne Maurer, Jutta Thödtmann - 2003 - 120 pages
...cancer: preliminary efficacy results from the ZEBRA study. Breast (2001) 10 (1): S30 (p 53) Slamon DJ et al.: Use of chemotherapy plus a monoclonal antibody...breast cancer that overexpresses HER2. N Engl J Med (2001) 344: 783-792 Tumorzentrum München: Empfehlungen zur Diagnostik, Therapie und Nachsorge. Mammakarzinome.... | |
 | Vincent T. Devita - Cancer - 2003 - 448 pages
...HER2-overexpressing metastatic breast cancer. J Clin Oncol. 2002:20:719-726. 97. Slamon DJ, Leyland-Jones B, Shak S et al. Use of chemotherapy plus a monoclonal antibody...breast cancer that overexpresses HER2. N Engl J Med. 2001:344:783-792. 98. Campos L, Rouault JP, Sabido O et al. High expression of bcl-2 protein in acute... | |
 | Giancarlo Pillot, Marcia Chantler - Medical - 2004 - 302 pages
...proto-oncogene in human breast and ovarian cancer. Science 1989;8:2127. Slamon DL, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody...breast cancer that overexpresses HER2. N Engl J Med 2001;344:78. Thomas DB. Breast cancer in men. Epidemiol Rev 1993;15:220. Thomas DB, Jimenez LM, McTiernan... | |
 | Antonio Llombart Bosch, Vicente Felipo - Medical - 2003 - 312 pages
...combinations in metastatic breast cancer. Semm Oncol 2002; 29:38-43. 57. Slamon DJ, Leyland- Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody...breast cancer that overexpresses HER2. N Engl J Med 2001 ; 344:783-792. 58. Albanell J. Baselga J. Unraveling resistance to trastuzumab (Herceptin): insulin-like... | |
 | Frédérique Penault-Llorca - 2003 - 102 pages
...metastatic breast cancer. / Clin Oncol 2002 ; 20 (6) : 1467-72. 18. Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody...metastatic breast cancer that overexpresses HER2. N Engl J Meil 200 1 ; 344 ( 1 1 ) : 783-92. 19. Bast RC, Jr., Ravdin P, Hayes DF, et al. 2000 update of recommendations... | |
 | Everett E. Vokes, Harvey M. Golomb - Medical - 2002 - 686 pages
...Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L (2001 ) Use of chemotherapy plus a monoclonal antibody against...breast cancer that overexpresses HER2. N Engl J Med 344:783 25. Clynes RA, Towers TL, Presta LG, Ravetch JV (2000) Inhibitory Fc receptors modulate in... | |
 | Michael J. Fisch, Eduardo Bruera - Medical - 2003 - 532 pages
...Study Group [see commentsJ . N Engl J Med 1996;335: 1 785-9 1 . Slamon DJ, Leyland- Jones B, Shak S et al. Use of chemotherapy plus a monoclonal antibody...metastatic breast cancer that overexpresses HER2. N£ng//MeJ2001;344:783-92. Swenerton KD, Legha SS, Smith T et al. Prognostic factors in metastatic... | |
| |
Slamon DJ, Leyland-jones B, Shak S et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. 
